Find Practice Guidelines
The HIV Medicine Association is an organization of medical professionals who practice HIV medicine. We represent the interests of our patients by promoting quality in HIV care and by advocating for policies that ensure a comprehensive and humane response to the AIDS pandemic informed by science and social justice.
Congress Advancing Permanent SGR Repeal
The House and Senate appear ready to consider a permanent repeal of the Medicare Sustainable Growth Rate formula, which has threatened access to care for more than a decade. IDSA members asked to join final advocacy push.
IDSA Spearheads Advocacy Effort for AR Funding
IDSA was joined by 56 groups in a letter to congressional appropriators calling for funding to address antimicrobial resistance.
Better Tests, Better Care: The Promise of Next Generation Diagnostics
This report for policymakers highlights the need for new diagnostics and recommends policies to stimulate diagnostics R&D and clinical integration.
IDSA Provides Testimony in Support of Supplemental Funding for Ebola Preparedness and Response Efforts
IDSA voiced support for the President’s emergency funding request to Congress to address Ebola and has also volunteered to lend its expertise and resources to aid in the U.S. and global response to the outbreak in a communication to Ebola Czar, Ron Klain.
IDSA, PIDS, and HIVMA Comments on NIH Physician-Scientist Workforce Report
IDSA, along with PIDS and HIVMA, jointly commented on the NIH Physician-Scientist Workforce Working Group report highlighting recommendations to improve the state of the physician-scientist workforce.
IDSA President Provides Testimony on the Need for New Antibiotics
On September 19th,
IDSA President Barbara Murray provided testimony to the Health Subcommittee of
the House Energy & Commerce Committee on the need for a coordinated federal
strategy to spur research and development for new antibiotics.
Tell Congress #CutsHurt!
Your help is needed to send a strong message to Congress that federal agency and program funding levels need to be finalized in the weeks ahead, so that new cuts are not set into motion.
Take Three Minutes to Support Antibiotic Development
Urge Congress to help speed patient access to the most urgently needed new antibacterial drugs.
1 of 8
Outbreak of Recent HIV and HCV Infections among Persons Who Inject Drugs
Clinical Advisory: Ocular Syphilis in the United States
Experiences of CDC and Emory Healthcare in Managing Persons Under Investigation for Ebola
FDA approves treatment for inhalation anthrax
>> Read More
Shortages of key antibiotics, including gold-standard therapies and drugs for resistant infections, are on the rise, a new study in CID finds.
The Infectious Diseases Society of America (IDSA) welcomes the release of the National Action Plan for Combating Antibiotic Resistant Bacteria (CARB).
A new study in CID suggests that nasal drops of harmless bacteria can inhibit the related bug that sometimes causes meningococcal disease.
From the President How to Avoid a Payment Penalty IDWeek 2015 IDSA Journal Club
Changes in the Physician Quality Reporting System (PQRS) have important implications. If you don’t report on relevant measures during this calendar year, you will see a payment penalty in 2017. See Manage Your Practice for IDSA’s guidance on relevant measures for ID specialists.
An upcoming section on hcvguidelines.org, a website developed by IDSA and AASLD in collaboration with IAS-USA will examine the cost-effectiveness of HCV treatment to help clinicians advise and educate their patients, which is the purpose of the guidance. The new section will not, however, make recommendations regarding the pricing of these therapies for the treatment of HCV.
The Infectious Diseases Society of America (IDSA), in partnership with the ABIM Foundation’s Choosing Wisely campaign, has released a list of five tests or treatments that physicians and patients should question.
1 of 7
| IDSA | Contact Us
© Copyright HIVMA 2012 HIV Medicine Association